Sign Up to like & get
recommendations!
0
Published in 2024 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2023.5318
Abstract: Key Points Question What is the mode of death and the association of dapagliflozin with cause-specific death in patients with heart failure with improved ejection fraction (HFimpEF)? Findings In this post hoc analysis of the…
read more here.
Keywords:
failure improved;
dapagliflozin;
mode death;
improved ejection ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz745.0467
Abstract: Few studies address long-term outcomes among patients with type 2 myocardial infarction (T2MI). It has been suggested that patients with T2MI with concomitant stable ischemic heart disease are at higher-risk. Our goals were two-fold. First,…
read more here.
Keywords:
death;
patients type;
term;
among patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Europace"
DOI: 10.1093/europace/euaa162.067
Abstract: Implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy (CRT) have both proven to reduce mortality in patients with heart failure (HF). However, randomised trials comparing CRT-pacemaker (CRT-P) vs CRT-defibrillator (CRT-D) are lacking. Understanding a patient’s…
read more here.
Keywords:
crt group;
mode death;
crt;
crt crt ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Membranes"
DOI: 10.3390/membranes11040270
Abstract: Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) might be a lifesaving therapy for patients with cardiac arrest and no return of spontaneous circulation during advanced life support. However, even with ECPR, mortality of these severely sick patients…
read more here.
Keywords:
death;
mode death;
cardiopulmonary resuscitation;
extracorporeal cardiopulmonary ... See more keywords